Tumor lysis syndrome in a patient with metastatic merkel cell carcinoma
โ Scribed by L. Y. Dirix; A. Prove; D. Becquart; E. Wouters; P. Vermeulen; A. van Oosterom
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 386 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Merkel cell carcinoma (MCC) is a highly malignant skin neoplasm. Regional lymph node and distant metastasis occur in 20 -52% of patients. The role of chemotherapy in the treatment of patients with this rare tumor is unclear. METHODS. An exhaustive analysis of the literature (1980
## BACKGROUND. Merkel cell carcinoma (MCC) has been associated with a high incidence of other skin tumors and hematological malignancies. The purpose of this study was to analyze data from the Israel Cancer Registry regarding the incidence of second neoplasms in patients with MCC and their impact
Eighty-two patients with metastatic germ cell tumors (GCT) treated with two-drug therapy consisting of etoposide and cisplatin were evaluated for late relapse. Goodrisk GCT was defined using Memorial Sloan-Kettering Cancer Center (MSKCC) criteria. Etoposide was given a t 100 mg/mz on days 1 to 5 and